World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
25015
World Ranking
13747
National Ranking
409

Overview

Nobuyuki Miyasaka is affiliated with Tokyo Medical and Dental University in Japan. Their primary field of research is Medicine, with a significant focus on Rheumatology. They have contributed extensively to studies related to autoimmune and inflammatory disorders, with notable research interests spanning rheumatoid arthritis and systemic lupus erythematosus.

The scientist's work encompasses several main topics, including:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • HER2/EGFR in Cancer Research
  • Chronic Lymphocytic Leukemia Research
  • Autoimmune and Inflammatory Disorders Research
  • Multiple Myeloma Research and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment

Several papers authored or coauthored by Nobuyuki Miyasaka provide insight into their research focus. Notable recent publications include:

  • Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study, published in 2020 in Lara D. Veeken
  • Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts, published in 2021 in Lara D. Veeken
  • An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up, published in 2020 in Rheumatology Advances in Practice
  • Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - A systematic review and meta-analysis, published in 2020 in Modern Rheumatology
  • Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis, published in 2020 in International Journal of Rheumatic Diseases

Miyasaka frequently publishes in specific venues, reflecting their engagement with leading journals in rheumatology and related fields:

  • Lara D. Veeken
  • Rheumatology Advances in Practice
  • Modern Rheumatology
  • International Journal of Rheumatic Diseases
  • Arthritis Research & Therapy

The scientist often collaborates with several coauthors across their work, including:

  • Takahiko Sugihara
  • Tadashi Hosoya
  • Hiroyuki Baba
  • Fumio Hirano
  • Masayoshi Harigai

Subfields of study for Nobuyuki Miyasaka extend beyond rheumatology to include genetics, hematology, oncology, and epidemiology, showing a multidisciplinary approach to medical research.

Best Publications

  • Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial

    Norihiro Nishimoto;Kazuyuki Yoshizaki;Nobuyuki Miyasaka;Kazuhiko Yamamoto

  • Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

    Norihiro Nishimoto;Jun Hashimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto

  • Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

    T Hirano;T Matsuda;M Turner;N Miyasaka

  • Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides

    H Sakurai;H Kohsaka;M F Liu;H Higashiyama

  • Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation

    Tetsuya Fukuda;Takehiko Yoshida;Seiji Okada;Masahiko Hatano

  • Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy

    Norihiro Nishimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto;Shinichi Kawai

  • Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

    Norihiro Nishimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto;Shinichi Kawai

  • Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity

    Takashi Fujibayashi;Susumu Sugai;Nobuyuki Miyasaka;Yoshio Hayashi

  • Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

    Y Tanaka;T Takeuchi;T Mimori;K Saito

  • Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction.

    Nobuyuki Miyasaka;Kazuto Sato;Makoto Goto;Minoru Sasano

  • Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B

    Masayoshi Harigai;Manabu Kawamoto;Masako Hara;Tetsuo Kubota

  • Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

    Hiroshi Chin;Ayako Arai;Hiroshi Wakao;Ryuichi Kamiyama

  • Specificity of antibodies to type II collagen in rheumatoid arthritis.

    Kuniaki Terato;Kuniaki Terato;Yasunori Shimozuru;Kou Katayama;Yoshiharu Takemitsu

  • Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis.

    Ken Taniguchi;Hitoshi Kohsaka;Naoki Inoue;Yoshio Terada

  • Chemokines Regulate IL-6 and IL-8 Production by Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis

    Toshihiro Nanki;Kenji Nagasaka;Kenji Hayashida;Yuji Saita

  • Amelioration of Collagen-Induced Arthritis by Blockade of Inducible Costimulator-B7 Homologous Protein Costimulation

    Hideyuki Iwai;Yuko Kozono;Sachiko Hirose;Hisaya Akiba

  • Upregulated expression of chemokines in herniated nucleus pulposus resorption.

    Hirotaka Haro;Kenichi Shinomiya;Hiromichi Komori;Atsushi Okawa

  • Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.

    Fumitaka Mizoguchi;Yayoi Izu;Tadayoshi Hayata;Hiroaki Hemmi

  • Pneumocystis pneumonia associated with infliximab in Japan.

    Masayoshi Harigai;Ryuji Koike;Nobuyuki Miyasaka

  • Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome.

    N Miyasaka;B Sauvezie;D A Pierce;T E Daniels

Frequent Co-Authors

Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Takao Koike
Takao Koike Hokkaido University
Hisashi Yamanaka
Hisashi Yamanaka International University of Health and Welfare
Naoki Ishiguro
Naoki Ishiguro Nagoya University
Kusuki Nishioka
Kusuki Nishioka St. Marianna University School of Medicine
Katsumi Eguchi
Katsumi Eguchi Nagasaki University
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Noboru Mizushima
Noboru Mizushima University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in the healthcare field can complement or diversify your medical education. Many professionals consider graduate programs in healthcare administration. When selecting a management track, it’s important to understand how to evaluate healthcare administration degree programs for accreditation, flexibility, and career outcomes.

Practicing nurses aiming to advance may look for reputable bridge programs. There are accredited rn to bsn online no clinicals accredited programs that eliminate the need for on-site clinicals, making it easier for working professionals to earn their BSN remotely.

For nurses interested in leadership or advanced practice roles, doctoral degrees are available through online pathways. Some of the fastest msn to dnp program options offer accelerated completion timelines, helping you reach your goals faster. Those seeking a less intensive workload can explore the easiest dnp programs, which offer greater flexibility while still leading to valuable doctoral credentials.

These related online pathways expand your career options in the health sector—whether you are just starting or looking to advance your expertise in medicine or healthcare administration.

Best Scientists Citing Nobuyuki Miyasaka

Trending Scientists

Recently Published Articles